IP Verse

Melflufen Dosage Regimens For Cancer - EP3383385

EP3383385

ONCOPEPTIDES
Application Number
EP16805792A
Filing Date
Dec 1, 2016
Status
Patent Maintained As Amended
Aug 4, 2023
Grant Date
Sep 6, 2023
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3383385B2 was granted to Oncopeptides on Sep 6, 2023 following the initial filing on Dec 1, 2016 under the application number EP16805792A . The current legal status of the patent is Patent Maintained As Amended.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

LUIGIApr 29, 2021ADMISSIBLE
SYNTHONApr 28, 2021ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents